Ultrasound renal denervation: RADIANCE-HTN SOLO results
This video is supported by ReCor Medical
Summary
What is the latest evidence on the efficacy and safety of ultrasound renal denervation in treating hypertension? Reintroducing antihypertensive medication to patients previously treated with renal denervation is under discussion as Felix Mahfoud, Michel Azizi and Ajay Kirtane consider the 6-month results from the RADIANCE-HTN SOLO trial. Find out more about other renal denervation trials using an ultrasound catheter and what the future holds for this technology...
This interview supported by ReCor Medical was filmed at EuroPCR 2019: see more videos here…